Veterinary Clinical Pathology, published by Wiley, stands as a crucial resource within the realm of veterinary science, particularly focusing on the intricate field of clinical pathology. Established in 1977, this journal has been at the forefront of advancing knowledge and research, with a converged publication timeline stretching to 2024. With an ISSN of 0275-6382 and an e-ISSN of 1939-165X, it is recognized for its rigorous contributions to the field, achieving a commendable Scopus rank of #87 in General Veterinary, placing it in the 55th percentile among its peers. While it operates under a subscription model, its impact is underscored by its Q2 ranking in the Veterinary category and Q3 in the broader Medicine category for 2023. As a platform for researchers, professionals, and students alike, Veterinary Clinical Pathology aims to disseminate significant findings, foster interdisciplinary collaboration, and enhance the understanding of pathophysiological processes in animals, ultimately contributing to better clinical outcomes and animal health management.

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.

Abdominal Radiology is an esteemed journal published by Springer, focusing on the intricate and evolving field of abdominal imaging. With its ISSN 2366-004X and E-ISSN 2366-0058, this journal serves as a vital platform for disseminating high-quality research and clinical findings that advance both the understanding and practice of radiology specifically related to abdominal diseases. With a commendable impact, categorized in 2023 as Q2 in the fields of Gastroenterology, Radiological and Ultrasound Technology, and Radiology, Nuclear Medicine and Imaging, and Q1 in Urology, it attracts an audience eager for cutting-edge insights. Furthermore, its ranking in Scopus reflects its strong influence, with a notable position of #21 in Urology and #92 in Radiology. The journal adopts an Open Access model, facilitating a wider dissemination of knowledge and promoting collaborative research efforts on a global scale. The convergence of contributions from established researchers and emerging professionals alike enriches its content from 2016 to 2024, ensuring that readers remain at the forefront of abdominal diagnostics and therapeutic advancements.

Clinical Neuroradiology, published by SPRINGER HEIDELBERG, is a leading journal in the fields of neurology and radiology, focusing on the intersection of clinical practice and cutting-edge imaging technologies. With an impressive impact factor and categorized within Q2 in Neurology (clinical) and Q1 in Radiology, Nuclear Medicine and Imaging, this journal is positioned at the forefront of scientific discourse, facilitating high-quality research dissemination from its origins in 2000 through to 2024. Situated in Germany, Clinical Neuroradiology provides a platform for researchers, professionals, and students to explore the latest advancements and insights in neuroimaging, ensuring that its readership remains at the vanguard of clinical practice. While it does not offer open access, the journal remains committed to fostering a vibrant academic community dedicated to enhancing patient care through innovative neuroradiological techniques and findings.

Journal of Cytology, published by Wolters Kluwer Medknow Publications, stands as a pivotal resource in the fields of cytology, histology, and pathology. With an ISSN of 0970-9371 and an E-ISSN of 0974-5165, this peer-reviewed, open-access journal has been disseminating vital research since its inception in 1985, transitioning to open access in 2008 to enhance global accessibility to its scholarly articles. Operating from its base in Mumbai, India, the journal is categorized in the Q3 quartile for histology and pathology according to the 2023 rankings, affirming its ongoing contribution to the scientific community. Researchers and professionals can benefit from a wide array of cutting-edge studies and reviews that advance the understanding of cytological practices. The journal's commitment to disseminating high-impact research is reflected in its Scopus rankings, positioning it among the significant players in its field. By facilitating open access, the Journal of Cytology aims to foster knowledge exchange and inspire new investigations among scholars, clinicians, and students alike.

DIAGNOSTIC CYTOPATHOLOGY is a scholarly journal dedicated to advancing the field of cytopathology through the publication of high-quality research and reviews. Founded in 1985 and published by Wiley, this journal provides vital insights into the diagnosis and management of diseases through cytological techniques. With a strong presence in the academic community, it currently holds a Q3 ranking in the fields of Histology, Medicine (miscellaneous), and Pathology and Forensic Medicine, reflecting its commitment to fostering knowledge and innovation in these areas. Researchers and clinicians alike can benefit from its comprehensive articles that delve into cutting-edge methodologies and diagnostic strategies. Although not an Open Access journal, DIAGNOSTIC CYTOPATHOLOGY remains a crucial resource for professionals seeking to enhance their understanding and practice in the diagnostic realm. With an ISSN of 8755-1039 and an E-ISSN of 1097-0339, the journal continues to publish impactful studies well into 2024, ensuring that essential advancements in cytopathology reach a global audience.

CytoJournal is a leading open-access journal focused on the fields of pathology and forensic medicine, published by SCIENTIFIC SCHOLAR LLC. With its esteemed reputation, the journal has achieved a Q2 ranking in the 2023 Category Quartiles in its field, indicating its significant contribution and impact among its peers. Over its convergence from 2004 to 2024, CytoJournal has established itself as a pivotal platform for researchers, professionals, and students to disseminate and exchange pioneering research findings related to cytopathology and diagnostic techniques. With an emerging Scopus rank of #115 out of 208 in the field, the journal maintains a solid percentile ranking of 44th, underlining its importance in the scientific community. CytoJournal's commitment to facilitating open access ensures that critical insights and advancements in pathology and forensic medicine are easily accessible to those at the forefront of this essential area of study.

Annals of Diagnostic Pathology, published by Elsevier Science Inc, is a pivotal journal in the field of diagnostic pathology that has significantly contributed to the advancement of medical science since its inception in 1997. With an ISSN of 1092-9134 and E-ISSN of 1532-8198, this esteemed journal is positioned within the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, reflecting its high-quality research contributions, showcased by its ranking at #73 out of 208 in Scopus for the latter category. The journal's scope encompasses various aspects of diagnostic pathology, from innovative techniques to critical reviews of pathologic findings, making it an essential resource for researchers, medical professionals, and students dedicated to enhancing diagnostic accuracy and patient care. Although it does not currently offer open access options, its wide readership and impactful publications continue to influence clinical practices and research agendas. With a convergence period extending to 2024, Annals of Diagnostic Pathology remains a leading platform for disseminating valuable knowledge in this dynamic field.

Cancer Cytopathology, published by Wiley, is an esteemed journal that plays a pivotal role in the fields of Cancer Research and Oncology. With a focus on the microscopic examination and analysis of cancerous cells, this journal serves as a crucial platform for disseminating high-quality research aimed at improving diagnostic techniques and therapeutic strategies. The journal holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, emphasizing its influence and importance within the scientific community. Additionally, it is recognized in the top 76th percentile in Medicine - Oncology and the 63rd percentile in Cancer Research according to Scopus rankings. Operating from the United States, Cancer Cytopathology is dedicated to fostering cutting-edge research and exploration in cytopathology, providing essential insights into cancer progression and management. Researchers and practitioners alike will find this journal invaluable for staying on the forefront of advancements in cancer diagnostics.

Diagnostic and Interventional Imaging, published by Elsevier Masson, stands as a prominent journal in the fields of Radiology, Nuclear Medicine, and Imaging. With a significant impact factor and a reputation for high-quality research, this journal is dedicated to advancing the understanding and application of diagnostic and interventional imaging techniques. It has achieved an impressive Q1 ranking across multiple categories including Medicine (miscellaneous) and Radiological and Ultrasound Technology, demonstrating its esteemed position within the academic community. The journal features cutting-edge studies and reviews, reflecting the latest innovations and practices from 2012 to 2024. Researchers, healthcare professionals, and students alike can look forward to accessing valuable insights that drive forward the discipline and improve patient outcomes, as evidenced by its robust Scopus rankings placing it among the top journals in its domain.